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Evaluation of major complications associated with percutaneous CT-guided biopsy of
lung nodules below 3 cm
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Background/aim: The aim of this study was to evaluate retrospectively the incidence and risk factors for the serious complications of
pneumothorax and/or parenchymal haemorrhage occurring after computed tomography (CT) guided transthoracic biopsy.
Materials and methods: The relation between the incidence of pneumothorax and parenchymal haemorrhage due to biopsy, age,
sex, lesion localization, lesion size, duration of the procedure, depth of lesion, number of pleural insertions of the biopsy needle and
pathology results were statistically evaluated.
Results: Between 2016 and 2017, 309 cases with lesions below 3 cm in diameter of a total of 768 (40.2%) CT-guided chest biopsy
patients were selected for retrospective review. The rate of pneumothorax and parenchymal haemorrhage was 18.1% (59/309) and 51%
(158/309), respectively post biopsy. The number of needle pleural insertions was correlated with the development of pneumothorax
(P = 0.002). At regression analysis, for parenchymal haemorrhage, lesion depth (P < 0.001) and total procedure time (p=0.036) were
determined as the most important independent risk factors.
Conclusion: Pneumothorax and parenchymal haemorrhage are common complications after CT-guided percutaneous biopsy. The
minimum number of needle-pleural insertions, the optimal access route to the lesion and as quick as possible biopsy procedure should
be selected to reduce the risk of pneumothorax and parenchymal haemorrhage.
Key words: Lung, biopsy, radiology, interventional

1. Introduction
Today, with advances in technology and widespread use
of radiological examinations, pulmonary masses tend
to be diagnosed earlier. Solitary pulmonary nodules are
malignant in between 20% and 40% of cases although in
the 55–75 years old age group this rate increases 1.2-fold
for every 10 years of additional age [1].
The development and use of percutaneous transthoracic
biopsy (PTB), has led to diagnostic accuracy rates of 75%–
81% [2]. Other diagnostic techniques include sputum
cytology, bronchoscopy, and thoracoscopy [3,4].
PTBs have become increasingly used due to the low risk
of serious complications, repeatability, compatibility with
local anaesthesia and low cost, as well as high diagnostic
accuracy [5,6]. Although the risk of complications is
perceived to be low, they occur nevertheless, with the
most common complications of PTB being pneumothorax
and parenchymal haemorrhage. In a meta-analysis, it was
reported that the rate of both pneumothorax (8.4%–45.3%)

and parenchymal haemorrhage (3.3%–54.5%) varied
widely following lung nodule biopsy [7]. Other possible
severe complications would include seeding of metastases
by shedding malignant cells from the biopsy needle and
haemoptysis [8,9]. Fatal complications such as pericardial
tamponade and systemic air embolism have rarely been
reported in the literature [8,10].
Lung nodules with size below 3 cm, considered as T1
(T for extent of the primary tumour) and those with a
size of above 3 cm are considered as T2 in the 8th edition
Lung Cancer Stage Classification [11]. According to
this classification, T1 and T2 tumours have a 5-year life
span of 92% and 68%, respectively [11]. Therefore, rapid
identification and resection of the pulmonary nodule is
crucial to improve prognosis and survival.
Lesion size, depth of the parenchyma and the number
of pleural needle entries have been associated with
pneumothorax and haemorrhage in the literature, although
reports are sometimes inconsistent and contradictory [12–
14].
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In this retrospective study, we aimed to evaluate the
relationship between pneumothorax and parenchymal
bleeding complications, age, sex, lesion location, lesion
depth, lesion size, duration of the procedure, number of
needle pleural insertions and pathology results as a result
of percutaneous transthoracic biopsy.
2. Material and methods
In this study, images of 768 patients, presenting to Kocaeli
University Medical Faculty Hospital between 2016–2017
who were investigated with CT-guided percutaneous
transthoracic biopsy because of lung nodules evident on
thoracic imaging, were evaluated.
2.1. Inclusion criteria
Patients with lung nodules less than 30 mm in diameter
without histopathologic diagnosis were detected by
computed tomography (CT) or positron emission
tomography (PET).
2.2. Exclusion criteria
Masses over 30 mm in size (n = 220), masses located on the
chest wall and mediastinum (n = 130), severe heart failure
(n = 62), severe renal or hepatic insufficiency (n = 27), and
patients determined to have complications such as preexisting severe haemorrhage (n = 12) or pneumothorax
(n = 8) which would have compromised the safety of the
biopsy during the procedure were excluded from the study.
Lesion size, location, depth, duration of procedure, the
number of sampling attempt and histopathological data
were evaluated as the main factors affecting pneumothorax
and the rate of haemorrhage after the biopsy procedure.
Procedures were performed by 2 experienced radiologists
with more than 5 years’ of experience regarding
transthoracic biopsy (ÖÇ, İÇ).
The lesions were divided into 3 groups according
to their largest diameter: <10 mm, 10–19 mm, 20–29
mm. The lesions were divided into 5 groups according
to their location: left upper, left lower, right upper, right
middle, and right lower. Benign lesions were divided into
4 groups according to pathology: organized pneumonia,
hamartoma, anthracosis, and tuberculosis. Malignant
lesions were also divided into four groups according to
pathology: adenocarcinoma, squamous cell cancer, small
cell cancer, and metastasis. The lesions were also classified
according to position and divided into 3 groups: 20 mm
and less, 21–40 mm, and more than 41 mm based on the
shortest distance to the pleura.
Pneumothorax development was evaluated by post
biopsy images. After the procedure, the development
of parenchymal haemorrhage was evaluated. The
haemorrhage was classified according to their longest
dimension as 20 mm below, between 21–50 mm and
above 51 mm. Procedure times were calculated based on
the time interval between admission of the patient to CT
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unit and the last CT scan for examination. Biopsy needle
applications (NoP) were recorded, based on each pleural
entry procedure for biopsy.
For this study, verbal and written informed consent
was obtained from all patients before the procedure with
the approval of ethics committee.
2.3. Procedure
Bleeding time and full blood count were obtained from all
patients. Preoperative imaging studies (CT, PET CT) were
examined to determine the lesion location in the lung
and the relationship of the lesion to surrounding vascular
structures and organs. All biopsies were performed on a
16-section multislice CT machine (Aquilion, Toshiba,
Tokyo, Japan) using a 17 G coaxial needle and an 18G fully
automated tru-cut gun (Bard Monopty Disposable Core
Biopsy Instrument, Bard, Tempe, Ariz). The procedures
were planned as the shortest path from the skin to the
lesion and the patients were biopsied in supine, prone, and
oblique positions. The entry point is marked on the skin by
using CT scan, without penetrating the pleura, and local
anaesthesia was applied with 2% lidocaine. The distance of
the needle to the pleura and other structures were evaluated
and pleura was passed after puncture. After reaching
the target lesion with the coaxial needle, fine needle
aspiration biopsy and tru-cut biopsy were performed.
Biopsy procedure was performed at least twice, taking the
patient’s tolerance and the adequacy of the specimen into
consideration. Samples were prepared on a microscope
slide and those taken with the tru-cut gun were put into
4% formaldehyde for fixation and sent to the pathology
laboratory.
CT images obtained after removal of the coaxial needle
were used to evaluate complications. After the procedure,
the patients developing small pneumothorax received
oxygen-bed rest for 24 hours and they were evaluated
by chest x-ray. A chest tube was used in patients with
significant dyspnoea haemorrhage and pneumothorax.
2.4. Statistical analysis
Measurement data were expressed as mean ± standard
deviation, nominal and categorical data were expressed
as number (n) and frequency (%). According to the
normality test result, the Mann–Whitney U test and
Independent samples t-test were used for between-group
comparisons. Categorical variables were compared using
the chi-square test. The relationships between variables
were examined using correlation analysis and Spearman
correlation coefficient was calculated. The variables which
were found statistically significant at correlation analysis
on complication (dependent variable) were examined with
multivariate binary logistic regression analyses. Value of
P < 0.05 was considered statistically significant. Statistical
analysis was performed using statistical package for the
social sciences, version 21 (IBM Corp., Armonk, NY USA).
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3. Results
Between 2016 and 2017, 768 patients who underwent
percutaneous transthoracic biopsy were evaluated and 309
patients with lesions of <30 mm by largest diameter were
included in the study. The fine needle and tru-cut biopsies
were performed in all patients (Figure 1,2).
The mean age, standard deviation of the patients (62.6
± 10.9 years; range, 28–87 years): 244 men (mean age, 63.1
± 10.5 years) and 95 women (mean age, 60.5 ± 13.3 years).
The mean lesion size was 19.9 ± 6.9 mm. The distribution
of locations was; right upper 115 (37.2%), right middle
26 (8.4%), right lower 43 (13.9), left upper 68 (22%), left
lower lobe 57 (18.4%). The mean lesion depth was 14 ±
6.5 mm. It was found that 285 (92.2%) patients required
a single penetration, 20 (6.5%) required 2 penetrations,
and 4 (1.3%) of the patients required 3 penetrations. Mean
procedure time was determined as 20.5 ± 6.9 min (Table 1).
The lung lesions included in the study were divided by
size range less than 30 mm. The mean size of the lesions was
21 mm. The distribution of the size of the lesions was: 31
(10%) between 0 and 10 mm; 122 (39.5%) between 11 and
20 mm; and 156 (50.5%) between 21 and 30 mm (Table 1).
According to the biopsy results, 211 benign (68.3%)
and 98 malignant (31.7%) masses were detected. Benign
masses included organized pneumonia (130, 61.6%),
hamartoma (39, 18.5%), chronic fibrosis-anthracosis (28,
13.3), tuberculosis (17, 31.7). Malignant masses included
adenocarcinoma (47, 48%), small cell lung cancer (34,
34.7%), metastasis (11, 11.2%), squamous cell lung cancer
(3, 3.1%), and mesothelioma (3, 3.1%) (Table 1).
Pneumothorax and parenchymal hemorrhage were
evaluated after biopsy. Pneumothorax was developed
in 56 (18.1%) patients who underwent biopsy, and the
mean thickness of pneumothorax was 8 ± 5.9 mm. Tube
thoracostomy was performed in 7 patients (12.5%), and
there was no patient death due to pneumothorax (Table 1).
Parenchymal haemorrhage developed in 158 (51.1%)
of the patients who underwent biopsy, and no bleeding
occurred in 151 (48.9%) patients. Mild bleeding (113,
36.6%), moderate bleeding (41, 13.3%), and severe bleeding
(4, 1.3%) was detected (Table 1). Four patients with severe
parenchymal haemorrhage and patients with moderate
bleeding were discharged 1–3 days after clinical followup. Bronchial artery embolization was not required in any
patient following bleeding. Patient death did not occur due
to postoperative complications.
After PTB, factors that may affect the risk of
pneumothorax and parenchymal bleeding were evaluated
(Table 2). As the NoP increased there was a significant
increase in the risk of pneumothorax development after
transthoracic biopsy. No significant effect was found for an
increased risk of pneumothorax occurrence for patient age,
sex, lesion location, lesion size, procedure duration, lesion
depth, and lesion pathology.

Figure 1. CT-guided lung biopsy of left sided 16 mm pulmonary
nodule and parenchymal haemorrhage during biopsy.

Figure 2. CT-guided lung biopsy of right sided 24 mm pulmonary
nodule (white arrow) with tru-cut biopsy needle (star) and
pneumothorax (black arrow).

There was a significant difference related to lesion size,
lesion depth and procedure time between parenchymal
haemorrhage present or absent groups (P = 0.001, P <
0.001, P < 0.001, respectively). The risk of parenchymal
haemorrhage occurrence and resulting haemorrhage size
were both found to be significantly associated with lesion
size, depth of lesion and longer duration of the procedure
(Table 2). There was no increase in risk of haemorrhage
due to gender, age, lesion localization, NoP or lesion
pathology after the biopsy procedure (Table 2).
At multivariate binary logistic regression analyses,
depth of lesion and procedure time were determined as an
independent risk factors increasing the risk of parenchymal
haemorrhage (Table 3).

371

ÇAKIR et al. / Turk J Med Sci
Table 1. Characteristics of the 309 study patients. Data are given as n (%) or mean ± standard
deviation.
Sex

Procedure time (min)

20.5 ± 7.5
14 ± 6.5

Male

244 (79%)

Lesion depth (mm)

Female

6 (21%)

Number of punctures

Age (years)

62.6 ± 10.9

1

285 (92.2%)

Lesion localization

2

20 (6.5%)

- Left upper lobe

68 (22%)

3

4 (1.3%)

- Left lower lobe

57 (18.4%)

Pathology results

- Right upper lobe

115 (37.2%)

Benign

211 (68.3%)

- Right middle lobe

26 (8.4%)

- Organized pneumonia

130 (61.6%)

- Right lower lobe

43 (13.9%)

- Hamartoma

39 (18.5 %)

Lesion size (mm)

19.9 ± 6.9

- Chronic fibrosis-anthracosis

28 (13.3%)

Pneumothorax

56 (18.1%)

- Tuberculosis

14 (6.6 %)

Pneumothorax size (mm)

8 ± 5.9

Malignancy

98 (31.7%)

Haemorrhage

158 (51.1%)

- Adenocarcinoma

47 (48 %)

- None

151 (48.9%)

- Small cell lung cancer

34 (34.7%)

- Mild (0–20 mm)

113 (36.6%)

- Metastasis

11 (11.2 %)

- Moderate (20–50 mm)

41 (13.3%)

- Squamous cell lung cancer

3 (3.1%)

- Severe (50 mm-up)

4 (1.3%)

- Mesothelioma

3 (3.1%)

Table 2. The relationship between risk factors and complications (pneumothorax and parenchymal haemorrhage) were demonstrated.
Complications

Pneumothorax

Haemorrhage

Haemorrhage size

ra

p

ra

p

ra

p

Sex

0.016

0.778

–0.099

0.082

–0.083

0.143

Age (years)

0.026

0.645

–0.058

0.306

–0.049

0.389

Lesion localization

0.005

0.932

–0.065

0.254

–0.056

0.325

Lesion size (mm)

0.030

0.595

–0.188

0.001

–0.212

<0.001

Procedure time (min)

0.036

0.527

0.225

<0.001

0.241

<0.001

Lesion depth (mm)

–0.020

0.732

0.399

<0.001

0.433

<0.001

Number of punctures (NoP)

0.345

0.002

–0.044

0.431

0.065

0.255

Pathology results

–0.004

0.940

–0.057

0.316

–0.077

0.177

Footnote: a Spearman correlation coefficient.

4. Discussion
The most common complication encountered in the
literature following PTB is parenchymal haemorrhage
with a rate of 51.1% (158/309), as in our study [7]. Most of
the cases in our series experienced only mild to moderate
haemorrhage and bronchial embolization was not required
in any cases. In addition, there was no patient death.
Pulmonary hemorrhage showed significant correlation
with lesion size, lesion depth and procedure time.
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The factor of lesion depth was determined to
independently increase the risk of haemorrhage (OR,
1.041; 95% CI, 1.025:1.056; P < 0.001). The relationship
between pulmonary nodule depth (pathway) and
pulmonary haemorrhage can be explained by the small
size of the lesion (less than 3 cm by design), a large
number of needle entries, a greater distance between
the nodule-pleura and the proximity to the pulmonary
vessels.
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Table 3. Multivariate binary logistic regression analysis of risk factors of haemorrhage

B

SE

Wald

p

OR

Procedure time

0.039

0.019

4.400

0.036

Lesion depth

0.040

0.008

27.414

Lesion size

–0.037

0.019

3.814

Constant

–0.757

0.600

1.596

95% CI for OR
Lower

Upper

1.040

1.003

1.079

0.000

1.041

1.025

1.056

0.051

0.964

0.929

1.000

0.206

0.469

Abbreviations: CI, confidence interval; OR, odds ratio; SE, standard error.

In our study, the relationship between nodule size and
pulmonary haemorrhage is in agreement with the literature
[15,16]. It has been hypothesised that small nodule
biopsies are more difficult and therefore time consuming.
In addition, small lesions often require multiple biopsy
attempts increasing the NoP [16]. Significant correlation
was also found between an increase in the duration of
the procedure and haemorrhage. The factor of procedure
time was determined to independently increase the
risk of haemorrhage (OR, 1.040; 95% CI, 1.003:1.079; P
= 0.036). Our findings also suggested that smaller size
of nodule tended to prolong the procedure time and
led to an increase in the risk of complications. While
pulmonary haemorrhage can have serious life-threatening
consequences, this was not the case in our experience.
There was no need for treatment and no patient death in
our study.
We hoped to find a statistically significant correlation
between parenchymal haemorrhage and the number of
needle pleural insertion. However, the risk of parenchymal
bleeding was not correlated with an increased number of
needle entries.
Pneumothorax was the second most common serious
complication following PTB with a rate of 18.1% (56/309).
This finding is in concordance with the literature [17].
There was a significant correlation between the number of
needle entries and pneumothorax complications. Again,
this is in agreement with previous reports [13,18]. We
hypothesize that more needle entries lead to more defectinduced pneumothorax in the pleura during patient
inspiration.
There was no statistically significant correlation
between the development of pneumothorax following
PTB and gender, age, lesion location, lesion size, depth,
lesion pathology and procedure time. Our findings
concerning lesion depth and a lack of increased risk of
pneumothorax are in contrast to some previous reports
[16,19].
Contrary to some other reports, there was no
correlation between the development of pneumothorax
following PTB performed on small lesions in our study

[14,19]. However, our findings are in agreement with
previous studies which reported no significant relationship
between pneumothorax and lesion size [12,13].
This is the first study, to the best of our knowledge,
to investigate if there is any correlation between
histopathological diagnoses and pneumothorax and
parenchymal haemorrhage after PTB. We found
no significant statistical relationship between the
histopathological results of the lesions biopsied and
the development of pneumothorax or parenchymal
haemorrhage. It was thought that the inclusion of nodules
of less than 3 cm in maximum diameter and thus the
exclusion of large malignant tumours during biopsy
might affect the results. However, it has previously been
hypothesised that smaller lesions are technically more
difficult to handle and therefore would be more prone to
post-biopsy complications [12,13].
There are some limitations to our study. The most
important of these is the retrospective nature of the
study, performed by only 2 operators. The effect of the
experience of the operators, inter-operator comparison
and the relationship between complication occurrence
were not evaluated. In addition, the study did not examine
pulmonary functions and pulmonary emphysema-bulla
formations before the procedure. Pulmonary function is
not routinely evaluated in our clinic and therefore there
is no pre- and postbiopsy data concerning lung function.
Prior to the procedure, surgery-radiotherapy-cigarette
anamnesis, which could increase the risk of complications,
was not taken into consideration during the assessment of
data. In addition, body position (supine, prone, oblique)
during the procedure, and fissure formation within the
parenchyma during biopsy were not evaluated.
In conclusion, pneumothorax and parenchymal
haemorrhage are the most common complications of
CT-guided percutaneous lung biopsy. The data presented
here suggests that the most important risk factor in
the development of pneumothorax is the number of
needle entries. For parenchymal haemorrhage the most
important risk factors are the size of the lesion, duration of
the procedure and depth of the lesion. In order to reduce
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the proportion of patients experiencing complications, we
recommend making the duration of the procedure as short
as possible, which is dependent on operator experience to
some extent, planning access using shortest depth from
skin to lesion and using the minimum number of pleural
entries by biopsy needle to obtain adequate samples for
analysis.
Despite the limitations, the data obtained in our study
may prevent unnecessary complications by suggesting
how pre-procedure risk assessment may be modified
by improvement in procedure planning and by giving

important information to the clinician in reducing the
complication risk after percutaneous transthoracic biopsy.
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